Observational study of pre‐operative intravenous iron given to anaemic patients before elective cardiac surgery
Tóm tắt
Cardiac surgical patients with anaemia experience increased morbidity and mortality. Iron deficiency is the most common cause of pre‐operative anaemia in this group. We designed and implemented the Cardiff Pathway, a pre‐assessment and treatment pathway to identify cardiac surgical patients with anaemia and iron deficiency. Patients identified with anaemia and/or iron deficiency (Hb < 130 g.l‐1 and ferritin < 100 μg.l‐1) were offered intravenous iron infusion 20 mg.kg‐1 pre‐operatively. Treatment success was defined as Hb ≥ 130g.l‐1 on the day of surgery. We analysed data from 447 patients: 300 (67%) were not anaemic; 75 (17%) were anaemic and treated with intravenous iron; and 72 (16%) were anaemic and not treated. Haemoglobin concentration increased in successfully treated anaemic patients by a mean (95%CI) of 17 (13–21) g.l‐1 and they received a median (IQR [range]) of 0 (0–2 [0–15]) units of blood peri‐operatively. Transfusion was avoided in 54% of the successfully treated anaemic patients, which was significantly more than the unsuccessfully treated anaemic (22%, p = 0.005) and untreated anaemic (28%, p = 0.018) patients and similar to non‐anaemic patients who received a median (IQR [range] of 0 (0–1 [0–16])) units of blood and, 63% avoided transfusion). Mean (95%CI) Hb fell between pre‐assessment and surgery in the untreated anaemic (‐2 (0 to ‐4) g.l‐1) and non‐anaemic groups (‐2 (‐1 to ‐3) g.l‐1). Twenty‐one (7%) of the non‐anaemic group became newly anaemic waiting for surgery. The Cardiff Pathway reliably identified patients with anaemia and iron deficiency. Anaemic patients who had their Hb restored to normal after treatment required less blood peri‐operatively and over half of them required no transfusion at all.
Từ khóa
Tài liệu tham khảo
World Health Organization.Vitamin and mineral nutrition information system (VMNIS) haemoglobin concentrations for the diagnosis of anaemia and assessment of severity.2011.https://www.who.int/vmnis/indicators/haemoglobin/en/(accessed 28/06/2020).
Hogan M, 2014, The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery, European Journal of Cardiothoracic Surgery, 47, 1
Thakrar SV, 2017, Patient blood management and perioperative anaemia, British Journal of Anaesthesia Education, 17, 28
Cleland SR, 2019, Iron homeostasis and perioperative management of iron deficiency, British Journal of Anaesthesia Education, 19, 390
National Institute for Health and Care Excellence.Blood transfusion [NG24]. Recommendation 1.1.3.https://www.nice.org.uk/guidance/ng24/chapter/recommendations#alternatives‐to‐blood‐transfusion‐for‐patients‐having‐surgery‐2(accessed 21/11/2019).
PharmacosmosUK Limited.Monofer® 100mg/ml solution for injection/infusion.https://www.medicines.org.uk/emc/medicine/23669(accessed 05/07/2020).
Fang WC, 1997, Impact of minimum haematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery, Circulation, 96, 194
Hardy JF, 1998, Influence of haemoglobin concentration after extracorporeal circulation on mortality and morbidity in patients undergoing cardiac surgery, British Journal of Anaesthesia., 81, 38